Literature DB >> 9593679

Identification of a novel growth factor-like lipid, 1-O-cis-alk-1'-enyl-2-lyso-sn-glycero-3-phosphate (alkenyl-GP) that is present in commercial sphingolipid preparations.

K Liliom1, D J Fischer, T Virág, G Sun, D D Miller, J L Tseng, D M Desiderio, M C Seidel, J R Erickson, G Tigyi.   

Abstract

Lysophosphatidic acid, a member of the acidic phospholipid autacoid (APA) family of lipid mediators, elicits diverse cellular effects that range from mitogenesis to the prevention of programmed cell death. Sphingosine 1-phosphate and sphingosylphosphorylcholine have also been proposed to be ligands of the APA receptors. However, key observations that provide the foundation of this hypothesis have not been universally reproducible, leading to a controversy in the field. We provide evidence that 1-O-cis-alk-1'-enyl-2-lyso-sn-glycero-3-phosphate (alkenyl-GP) is present in some commercial sphingolipid preparations and is responsible for many of their APA-like effects, which were previously attributed to sphingosylphosphorylcholine. Alkenyl-GP was generated by acidic and basic methanolysis from ethanolamine lysoplasmalogen, which was present in the sphingomyelin fraction that is used to manufacture sphingosylphosphorylcholine. We present the structural identification of alkenyl-GP, using 1H and 13C NMR, Fourier transform infrared spectrometry, and mass spectrometry. Alkenyl-GP was a potent activator of the mitogen-activated protein kinases ERK1/2 and elicited a mitogenic response in Swiss 3T3 fibroblasts. In contrast, sphingosylphosphorylcholine at a concentration of 10 microM was only a weak mitogen and only weakly activated the extracellular signal-regulated protein kinases. Alkenyl-GP has recently been detected as an injury-induced component in the anterior chamber of the eye (Liliom, K., Guan, Z., Tseng, H., Desiderio, D. M., Tigyi, G., and Watsky, M. (1998) Am. J. Physiol. 274, C1065-C1074), indicating that this lipid is a naturally occurring member of the APA mediator family.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593679     DOI: 10.1074/jbc.273.22.13461

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Sphingosine-1-phosphate and sphingosylphosphorylcholine: two of a kind?

Authors:  Astrid E Alewijnse; Martin C Michel
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

2.  Expression of ectolipid phosphate phosphohydrolases in 3T3F442A preadipocytes and adipocytes. Involvement in the control of lysophosphatidic acid production.

Authors:  Marie Francoise Simon; Astrid Rey; Isabelle Castan-Laurel; Sandra Grés; David Sibrac; Philippe Valet; Jean Sébastien Saulnier-Blache
Journal:  J Biol Chem       Date:  2002-04-15       Impact factor: 5.157

3.  Synthesis of photoactivatable analogues of lysophosphatidic acid and covalent labeling of plasma proteins.

Authors:  Zaiguo Li; Daniel L Baker; Gabor Tigyi; Robert Bittman
Journal:  J Org Chem       Date:  2006-01-20       Impact factor: 4.354

4.  Hen egg yolk and white contain high amounts of lysophosphatidic acids, growth factor-like lipids: distinct molecular species compositions.

Authors:  S Nakane; A Tokumura; K Waku; T Sugiura
Journal:  Lipids       Date:  2001-04       Impact factor: 1.880

Review 5.  Aiming drug discovery at lysophosphatidic acid targets.

Authors:  Gabor Tigyi
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

Review 6.  From peroxisomal disorders to common neurodegenerative diseases - the role of ether phospholipids in the nervous system.

Authors:  Fabian Dorninger; Sonja Forss-Petter; Johannes Berger
Journal:  FEBS Lett       Date:  2017-09-07       Impact factor: 4.124

7.  Reduced muscle strength in ether lipid-deficient mice is accompanied by altered development and function of the neuromuscular junction.

Authors:  Fabian Dorninger; Ruth Herbst; Bojana Kravic; Bahar Z Camurdanoglu; Igor Macinkovic; Gerhard Zeitler; Sonja Forss-Petter; Siegfried Strack; Muzamil Majid Khan; Hans R Waterham; Rüdiger Rudolf; Said Hashemolhosseini; Johannes Berger
Journal:  J Neurochem       Date:  2017-09-25       Impact factor: 5.372

Review 8.  Regulation of Tumor Immunity by Lysophosphatidic Acid.

Authors:  Sue Chin Lee; Mélanie A Dacheux; Derek D Norman; Louisa Balázs; Raul M Torres; Corinne E Augelli-Szafran; Gábor J Tigyi
Journal:  Cancers (Basel)       Date:  2020-05-10       Impact factor: 6.639

Review 9.  Plasmalogens, platelet-activating factor and beyond - Ether lipids in signaling and neurodegeneration.

Authors:  Fabian Dorninger; Sonja Forss-Petter; Isabella Wimmer; Johannes Berger
Journal:  Neurobiol Dis       Date:  2020-08-28       Impact factor: 5.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.